142 related articles for article (PubMed ID: 11820592)
1. Tumour budding intensity in relation to cathepsin D expression and some clinicopathological features of colorectal cancer.
Famulski W; Guzińska-Ustymowicz K; Sulkowska M; Chabowski A; Zalewski B; Piotrowski Z; Stasiak-Barmuta A; Sulkowski S
Folia Histochem Cytobiol; 2001; 39 Suppl 2():171-2. PubMed ID: 11820592
[TBL] [Abstract][Full Text] [Related]
2. CD44 expression in colorectal cancer. An immunohistochemical study including correlation with cathepsin D immunoreactivity and some tumour clinicopathological features.
Zalewski B; Famulski W; Sulkowska M; Sobaniec-Lotowska M; Piotrowski Z; Kisielewski W; Sulkowski S
Folia Histochem Cytobiol; 2001; 39 Suppl 2():152-3. PubMed ID: 11820582
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer.
Mayer A; Fritz E; Fortelny R; Kofler K; Ludwig H
Cancer Invest; 1997; 15(2):106-10. PubMed ID: 9095205
[TBL] [Abstract][Full Text] [Related]
4. Activity of cathepsin B and D in colorectal cancer: relationships with tumour budding.
Guzińska-Ustymowicz K; Zalewski B; Kasacka I; Piotrowski Z; Skrzydlewska E
Anticancer Res; 2004; 24(5A):2847-51. PubMed ID: 15517887
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer.
Chabowski A; Sulkowska M; Sulkowski M; Famulski W; Skrzydlewska E; Kisielewski W
Folia Histochem Cytobiol; 2001; 39(2):153-4. PubMed ID: 11374801
[TBL] [Abstract][Full Text] [Related]
7. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
8. Tumour budding at invasive margins and outcome in colorectal cancer.
Kanazawa H; Mitomi H; Nishiyama Y; Kishimoto I; Fukui N; Nakamura T; Watanabe M
Colorectal Dis; 2008 Jan; 10(1):41-7. PubMed ID: 18078460
[TBL] [Abstract][Full Text] [Related]
9. Predictors of axillary lymph node metastases in patients with invasive breast carcinoma by a combination of classical and biological prognostic factors.
González-Vela MC; Garijo MF; Fernández FA; Buelta L; Val-Bernal JF
Pathol Res Pract; 1999; 195(9):611-8. PubMed ID: 10507081
[TBL] [Abstract][Full Text] [Related]
10. MMP-9 and cathepsin B expression in tumor budding as an indicator of a more aggressive phenotype of colorectal cancer (CRC).
Guzińska-Ustymowicz K
Anticancer Res; 2006; 26(2B):1589-94. PubMed ID: 16619576
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin D expression in human colorectal cancer: relationship with tumour type and tissue differentiation grade.
Sebzda T; Saleh Y; Gburek J; Andrzejak R; Gnus J; Siewinski M; Grzebieniak Z
J Exp Ther Oncol; 2005; 5(2):145-50. PubMed ID: 16471040
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin D expression in colorectal adenocarcinomas and adenomas.
Kanber Y; Demirbag NR; Sam AD; Aydin N
Int J Biol Markers; 2002; 17(3):165-8. PubMed ID: 12408466
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin D in invasive ductal NOS, medullary, lobular and mucinous breast carcinoma. An immunohistochemical study.
Bedner E; Harezga B; Osborn M; Domagała W
Pol J Pathol; 1995; 46(1):11-5. PubMed ID: 7780691
[TBL] [Abstract][Full Text] [Related]
15. The immunohistochemical expression of cathepsin D in colorectal cancer.
Valentini AM; Pirrelli M; Armentano R; Caruso ML
Anticancer Res; 1996; 16(1):77-80. PubMed ID: 8615673
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
Lugli A; Vlajnic T; Giger O; Karamitopoulou E; Patsouris ES; Peros G; Terracciano LM; Zlobec I
Hum Pathol; 2011 Dec; 42(12):1833-40. PubMed ID: 21664647
[TBL] [Abstract][Full Text] [Related]
17. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.
Ogawa T; Yoshida T; Tsuruta T; Tokuyama W; Adachi S; Kikuchi M; Mikami T; Saigenji K; Okayasu I
Scand J Gastroenterol; 2009; 44(5):605-14. PubMed ID: 19221929
[TBL] [Abstract][Full Text] [Related]
18. Predictive power of tumour budding for lymph node metastasis in colorectal carcinomas: A retrospective study.
Deb B; Jacob SE
Indian J Med Res; 2019 Dec; 150(6):635-639. PubMed ID: 32048628
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin-D expression in cervical carcinoma and its prognostic significance.
Mitchell KM; Hale RJ; Buckley CH; Fox H; Smith D
Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):357-60. PubMed ID: 8322451
[TBL] [Abstract][Full Text] [Related]
20. Tumour 'budding' and its relationship to p53 and Bcl-2 expression in colorectal cancer.
Guzińska-Ustymowicz K; Sulkowska M; Famulski W; Sulkowski S
Anticancer Res; 2003; 23(1B):649-53. PubMed ID: 12680162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]